ChromoGenics has appointed Björne Ekberg as procurement and logistics manager

  • 2017-05-16
  • Press release
ChromoGenics AB (publ) sees the growing demand for ConverLight ™ dynamic glass for solar control and increases production volumes. Björne Ekberg has been appointed Procurement and Logistics Manager. Björne brings extensive experience from growth companies and industrial expertise to ChromoGenics.

Björne has had strategic and operational roles in which he has successfully managed and developed relationships with subcontractors to ensure an efficient and quality assured supply of goods in international environments. Björne comes from Gyros, Uppsala, where he worked as a supply chain manager.

"We are very pleased to have Björne with us to take our procurement and logistics function to the next level. Björne has a long and broad industrial background focusing on quality throughout the supply flow for optimized customer and supplier relationships, "says Micael Hamberg, COO for ChromoGenics. "We are in an exciting growth phase. With Björne's extensive experience, he will handle subcontractors agreements in line with increasing volumes as well as ensure a delivery precision with high quality to our customers. "

"I look forward to contribute to ChromoGenic's growth journey," says Björne Ekberg. "ConverLight ™ dynamic glass for solar control is a product in time with a high value for sustainability. It is exciting that interest in the product is increasing and I look forward to ensure deliveries with satisfied customers as a focus, "concludes Björne.

Thomas Almesjö, CEO
Susanne Andersson, CFO & Head of Communications
Tel: +46 18 430 0430

About ChromoGenics
ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia.

ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.